It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2005.
2005 | Mumbai, Maharashtra, India | Struck OffS Sundarlal Pharma Private Limited, a struck off private limited company, was established on 11 May 2005 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24230MH2005PTC153178. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.15 M.
It upholds a compliant status. Its leadership includes Manoj Kishorchandra Sanghani (Director), Vikramaditya Harishchandra Ambre (Director). Past directors included Ramesh Harshi Chheda, Vinod Damji Shah, Bhavik Vinod Shah. It holds no open charges and ₹7.75 Cr settled loans. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at 10/14, Sachin Society, Mithagar Road Mulund (East),, Mumbai, Maharashtra, 400081.
U24230MH2005PTC153178
153178
11 May 2005
₹0.50 M
₹0.15 M
Roc Mumbai
Unlisted
Struck Off
Explore comprehensive insights into S Sundarlal Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manoj Kishorchandra Sanghani | Director | 28 Feb 2011 | Current |
| Vikramaditya Harishchandra Ambre | Director | 28 Feb 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Mar 2011 | Past |
| Pramod Abcsdd | Director | 01 Mar 2011 | Past |
| Pramod Abcsdd | Director | 01 Mar 2011 | Past |
| Pramod Abcsdd | Director | 01 Mar 2011 | Past |
| Pramod Abcsdd | Director | 24 Feb 2015 | Past |
| Pramod Abcsdd | Additional Director | 15 Feb 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
S Sundarlal Pharma Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 12.6% increase in profit. The company's net worth dipped by a decrease of 0.9%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, S Sundarlal Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹77,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Dec 2014 | Kotak Mahindra Bank Limited | ₹4.50 Cr | Satisfied |
| 04 Nov 2011 | Thane Bharat Sahakari Bank Limited | ₹3.25 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with S Sundarlal Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of S Sundarlal Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped S Sundarlal Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on S Sundarlal Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was documented.
The activity S Sundarlal Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Mumbai. was completed.
A charge registered on 31 Dec 2014 via Charge ID 10577531 with Kotak Mahindra Bank Limited was fully satisfied on 18 Jul 2019. was recorded as a recent event.
A charge registered on 04 Nov 2011 via Charge ID 10320614 with Thane Bharat Sahakari Bank Limited was fully satisfied on 20 Apr 2015. was recorded as a recent event.
Progress on A charge with Kotak Mahindra Bank Limited amounted to Rs. 45.00 M with Charge ID 10577531 was registered on 31 Dec 2014. was documented.
Progress on A charge with Thane Bharat Sahakari Bank Limited of Rs. 32.50 M registered on 04 Nov 2011 with Charge ID 10320614 was modified on 19 Mar 2014. was documented.
The CIN of S Sundarlal Pharma Private Limited is U24230MH2005PTC153178.
S Sundarlal Pharma Private Limited is headquartered at 10/14, Sachin Society, Mithagar Road Mulund (East),, Mumbai, Maharashtra, 400081.
S Sundarlal Pharma Private Limited was incorporated on 11 May 2005.
The current directors of S Sundarlal Pharma Private Limited are
The primary industry of S Sundarlal Pharma Private Limited is Trade.
S Sundarlal Pharma Private Limited is unlisted.
The authorized capital of S Sundarlal Pharma Private Limited is ₹0.50 M, and the paid-up capital is ₹0.15 M.
The compliance status of S Sundarlal Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX